Recent
Advances in Genetic Testing
Genetic Testing has now reached a stage where it is
becoming increasingly applicable for rapid and accurate
diagnosis of common infective / congenital disorders
as well as the basis for prediction of cancers and
lifestyle diseases.
These advances are opening up new avenues for the
clinicians to offer their patients innovative tools
to achieve optimum health. 'Advanced Genetic Testing
in the prediction & diagnosis of disease' conference
is aiming to introduce a broad spectrum of new diagnostic
tools available to clinicians in an attempt to incorporate
there use in routine practices.
The conference is proudly organized by Eastern
Biotech & Life Sciences; a Genetic Biotechnological
company based out of DuBiotech, Dubai and will be
held in Dubai (UAE) on the 27th of November 2008.
It is supported by the Ministry of Health, United
Arab Emirates and has been formally granted 3.0
CME credit points.
The conference aims to promote knowledge exchange
on using diagnostic testing as a tool for supporting
the advancement of genetic innovation throughout
the world. The conference will bring together approximately
75 key industry figureheads and stakeholders throughout
the GCC headlined by 4 internationally acclaimed
genetic specialists presenting their knowledge and
ideas fostering genetic and biotechnological innovation
specifically:
Genetic Disorders in Arab Populations
Syndrome Based Diagnostics: A Single Test using
DNA Macrochip to Detect Multiple Pathogens in Eye
and Brain
Birth Defects and Congenital Abnormalities in
UAE: Risk Reduction by Counseling and Genetic Testing
Using Molecular and Cytogenetic Techniques
New DNA Based Diagnostic Tests for Prediction
of Diabetes, Heart Disease, Breast and Prostate
Cancer
As a part of the event Eastern Biotech &
Life Sciences will conduct its inaugural network
meeting including product development and contribution
program aiming to enhance the education and management
of genetic diagnostic testing tools within the
GCC.
|
